NDC 50242-0109-01

Rituximab and hyaluronidase injection, subcutaneous vial at Presbyterian Medical Center of the University of Pennsylvania Health System D/B/A Penn Presbyterian Medical Center

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

RITUXIMABHYALURONIDASE HUMAN 160026800 MG UT/13.4M

Philadelphia, PA

See all hospitals reporting NDC 50242-0109-01 →

SharePost on X LinkedIn

Pricing by billing methodology

Price type

How this price compares nationally

Presbyterian Medical Center of the University of Pennsylvania Health System D/B/A Penn Presbyterian Medical Center’s median price of $10.8k is 98% above the median hospital's median price ($5.5k), higher than 67% of the 321 hospitals reporting NDC 50242-0109-01. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Mar 19, 2026

Compare to other hospitals

See Rituximab and hyaluronidase injection, subcutaneous vial pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.